Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ramipril (10mg) tablet
Therapeutic Category
Hypertension/ Blood Pressure, Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ramipril 10 mg Tablet is a high-strength angiotensin-converting enzyme (ACE) inhibitor widely used in the management of hypertension, heart failure, and to reduce cardiovascular risk in high-risk patients. It works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, leading to vasodilation, reduced systemic vascular resistance, and decreased blood pressure. Ramipril also reduces aldosterone secretion, minimizing sodium and fluid retention, which helps lower cardiac workload and protects kidney function. The 10 mg strength is typically prescribed as a maintenance dose for patients with severe hypertension or advanced heart failure who have been stabilized on lower doses. Apart from blood pressure control, Ramipril offers significant cardio-protective and reno-protective benefits, making it a key medication in patients with diabetes, chronic kidney disease, or those recovering from myocardial infarction.
Common side effects include dizziness, headache, fatigue, and a dry, persistent cough typical of ACE inhibitors. Some patients may experience hypotension (especially after the first dose), nausea, or mild gastrointestinal discomfort. Rare but serious adverse reactions include hyperkalemia, angioedema (swelling of the face, lips, or throat), and kidney impairment. Immediate medical attention is required if signs of angioedema or breathing difficulty occur.
Ramipril 10 mg Tablet is indicated for the management of moderate to severe essential hypertension, congestive heart failure, and to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients with a high cardiovascular risk profile. It is also prescribed to slow the progression of kidney disease in both diabetic and non-diabetic nephropathy.
Ramipril 10 mg should only be taken under the supervision of a qualified healthcare provider. It is contraindicated in pregnancy, especially in the second and third trimesters, due to the risk of fetal harm. Caution is advised in patients with severe kidney impairment, bilateral renal artery stenosis, or a history of angioedema. Potassium supplements and potassium-sparing diuretics should be avoided unless specifically prescribed, as ACE inhibitors may increase serum potassium levels. Alcohol intake should be minimized as it can enhance the blood pressure-lowering effect. The medication should not be discontinued abruptly; any dose change must be done gradually under medical advice. Routine monitoring of blood pressure, kidney function, and electrolytes is recommended for long-term safety and efficacy.
Store Ramipril 10 mg Tablet in a cool, dry environment below 30°C. Keep away from direct sunlight and moisture. Ensure the tablets are kept in their original packaging and out of reach of children. Do not use beyond the expiry date printed on the pack.
Composition : Metoprolol Succinate 50mg + Ramipril 5mg Tablet
Composition : Metoprolol Succinate 25mg + Ramipril 2.5mg Tablet
Composition : Ramipril (10mg) tablet
Composition : Ramipril 5 mg tablet
Composition : Ramipril 2.5 mg tablet
Composition : Ramipril 2.5 mg + amlodipine 5 mg tablet
Composition : Ramipril 5 mg + Hydrochlorothiazide 12.5 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ramipril 10 mg Tablet is a high-strength ACE inhibitor antihypertensive medication used for the management of moderate to severe hypertension (high blood pressure), chronic heart failure, and reduction of cardiovascular risk in high-risk patients. It works by relaxing blood vessels, improving blood flow, and reducing strain on the heart. This makes it a key product in the cardiology and cardiovascular care segment, with strong demand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and general practitioners. Due to the high prevalence of hypertension and long-term treatment requirements, Ramipril 10 mg ensures steady prescriptions, repeat purchases, and strong market stability, making it a valuable product for cardiovascular portfolios.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiac and antihypertensive segment with monopoly rights, quality manufacturing standards, attractive promotional support, and reliable supply chain assistance for distributors and franchise partners.
Wholesalers and distributors benefit from strong prescription volume, long-term patient adherence, increasing cardiovascular disease burden, and continuous institutional requirements, making this product a profitable and sustainable addition to their pharmaceutical business when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and antihypertensive formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiac segment.